Status:
COMPLETED
Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Paragangliomas
Pheochromocytomas
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
18F-FDOPA PET-CT is currently the gold standard in the evaluation of Pheochromocytomas and Paragangliomas (PHEO - PGL) since these tumors can also decarboxylate amino acids such as dihydroxyphenylalan...
Eligibility Criteria
Inclusion
- Age ≥ 18
- PHEO or PGL: initial staging or restaging
- Reference imaging within the last 2 months: multiphasic cervico-thoracoabdominal CT scan, 18F-FDOPA PET-CT and head and neck MRI (if head and neck localization
Exclusion
- Pregnant or breast-feeding woman
Key Trial Info
Start Date :
July 18 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 5 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02186678
Start Date
July 18 2014
End Date
April 5 2023
Last Update
April 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13005